Skip to content
Sialix Cancer Research

Sialix Cancer Research

Monoclonal antibodies

Menu
  • Home
  • Bacteria
  • Pig
  • Pigeon
  • Plant
  • plasmid
  • Plate
  • GMO
  • apoptosis
  • Goat
  • array
  • Assay
  • Blocking
  • 4 Host
  • 96T
  • Contact us
  • Our Distributors
  • Distributors
Menu
Application of tunable resistive pulse sensing for the quantification of submicron particles in pharmaceutical monoclonal antibody preparations

Application of tunable resistive pulse sensing for the quantification of submicron particles in pharmaceutical monoclonal antibody preparations

Posted on August 28, 2021September 4, 2021 by Cody

Tunable resistive pulse sensing (TRPS, qNano Gold, IZON Ltd.) was investigated as a way to quantify submicron particles (SMPs) between 0.1 and 1 µm in options of biopharmaceuticals. To cut back pattern dilution, a spiking-in method was used so as to add the applicable quantity of electrolytes required for the measurement. For right particle quantification, an electrolyte focus of at the very least 50 mM sodium chloride was wanted. Intra- and inter-nanopore variability had been beneath 5% for measurement and beneath 10% for focus measurements when analyzing polystyrene normal beads.

Submicron particle counts in a stir pressured IgG1 monoclonal antibody formulation resulted in a non-symmetrical, nearly bell-shaped measurement distribution with a most at 250 nm when utilizing a NP300 nanopore (IZON Ltd.). It was proven that particle counts are closely underestimated beneath 250 nm, and due to this fact it’s endorsed to quantify particle counts by TRPS in samples with heterogeneous particle measurement distributions (e.g., biopharmaceuticals) solely ranging from the most of the histogram in the direction of the higher restrict of detection.

Extremely drug-resistant (XDR) Acinetobacter baumannii is a infamous and ceaselessly encountered pathogen demanding novel therapeutic interventions. An preliminary monoclonal antibody (MAb), C8, raised in opposition to A. baumannii capsule proved a extremely efficient remedy in opposition to a minority of medical isolates. To overcome this limitation, we broadened protection by creating a second antibody for use in a mix routine.

Retrospective immunohistochemical investigation on dolphin morbillivirus an infection by evaluating the efficiency of heterologous monoclonal and polyclonal antibodies – Short communication

Dolphin morbillivirus (DMV) is a pathogen of nice concern in free-ranging cetaceans. Confirmation and staging of morbillivirus infections depend on histology and immunohistochemistry (IHC), following molecular detection. As at the current time no particular antibodies (Abs) in opposition to DMV can be found, two heterologous Abs have been used worldwide for the examinations of morbillivirus infections of cetaceans. One is a monoclonal Ab (MoAb) ready in opposition to the N protein of canine distemper virus (CDV), whereas the different is a polyclonal Ab raised in rabbits in opposition to rinderpest virus (RPV).

Both Abs are recognized to point out cross-reactivity with DMV. In this examine we in contrast the labelling high quality and the neuroanatomical distribution of staining with these two Abs by means of IHC evaluation. To this finish, serial sections of the goal organs from ten free-ranging stranded cetaceans, beforehand recognized as being contaminated with DMV by PCR and/or serology, had been subjected to IHC. The mind, lungs and lymph nodes of one animal had been discovered to be constructive with each Abs. From two different animals, the mind and the spleen, respectively, examined constructive solely with the polyclonal Ab. In the constructive mind tissues, multifocal immunostaining was noticed, with comparable staining location and extent, with the two antibodies examined.

Application of tunable resistive pulse sensing for the quantification of submicron particles in pharmaceutical monoclonal antibody preparations

Our outcomes counsel that the polyclonal anti-RPV Ab may need a stronger binding exercise to DMV than the anti-CDV MoAb. Nevertheless, the elaboration and use of particular anti-DMV Abs is perhaps important to ensure conclusive outcomes in diagnostic and pathogenetic investigations. We report the isolation of two human IgG1k monoclonal antibodies (mAbs) directed in opposition to the SARS-CoV-2 spike protein. These mAbs had been remoted from two donors who had recovered from COVID-19 an infection throughout the first pandemic peak in the Lombardy area of Italy, the first European and initially most affected area in March 2020.

We used the technique of EBV immortalization of purified reminiscence B cells and supernatant screening with a spike S1/2 assay for mAb isolation. This technique allowed fast isolation of clones, with one donor exhibiting about 7% of clones constructive in opposition to spike protein, whereas the different donor didn’t produce constructive clones out of 91 examined. RNA was extracted from constructive clones 39-47 days post-EBV an infection, permitting VH and VL sequencing. The identical clones had been sequenced once more after an extra 100 days in tradition, exhibiting that no mutation had taken place throughout in vitro growth.

Effects of Mild and Moderate Monoclonal Antibody Dose on Inflammation, Bone Loss, and Activation of the Central Nervous System in a Female Collagen Antibody-induced Arthritis Mouse Model

Induction of extreme inflammatory arthritis in the collagen antibody-induced arthritis (CAIA) murine mannequin causes in depth joint injury and pain-like habits compromising evaluation. While delicate fashions are much less extreme, their diminished, variable penetrance makes evaluation of remedy efficacy troublesome. This examine aimed to check macroscopic and microscopic modifications in the paws, together with central nervous system activation between a light and average CAIA mannequin. Balb/c mice (n=18) had been allotted to regulate, delicate, and average CAIA teams.

Bovine Angiotensinogen ELISA Kit

MBS037282-10x96StripWells MyBiosource 10x96-Strip-Wells
EUR 6725

Bovine Angiotensinogen ELISA Kit

MBS037282-48StripWells MyBiosource 48-Strip-Wells
EUR 550

Bovine Angiotensinogen ELISA Kit

MBS037282-5x96StripWells MyBiosource 5x96-Strip-Wells
EUR 3420

Bovine Angiotensinogen ELISA Kit

MBS037282-96StripWells MyBiosource 96-Strip-Wells
EUR 765

Bovine Angiotensinogen ELISA Kit

MBS2881823-10x96StripWells MyBiosource 10x96-Strip-Wells
EUR 4630

Bovine Angiotensinogen ELISA Kit

MBS2881823-48StripWells MyBiosource 48-Strip-Wells
EUR 440

Bovine Angiotensinogen ELISA Kit

MBS2881823-5x96StripWells MyBiosource 5x96-Strip-Wells
EUR 2480

Bovine Angiotensinogen ELISA Kit

MBS2881823-96StripWells MyBiosource 96-Strip-Wells
EUR 580

Bovine Angiotensinogen ELISA Kit

MBS742311-10x96StripWells MyBiosource 10x96-Strip-Wells
EUR 5685

Bovine Angiotensinogen ELISA Kit

MBS742311-48StripWells MyBiosource 48-Strip-Wells
EUR 485

Bovine Angiotensinogen ELISA Kit

MBS742311-5x96StripWells MyBiosource 5x96-Strip-Wells
EUR 3020

Bovine Angiotensinogen ELISA Kit

MBS742311-96StripWells MyBiosource 96-Strip-Wells
EUR 690

Bovine Angiotensinogen, AGT ELISA KIT

ELI-02700b Lifescience Market 96 Tests
EUR 1113.6

ELISA Kit for Bovine Angiotensinogen

E0797b EIAab 96T
EUR 441.6

Bovine Angiotensinogen (AGT) ELISA Kit  

EIA05226Bo Enlibio each
EUR 520

Bovine Angiotensinogen (AGT) ELISA Kit

MBS286843-10x96StripWells MyBiosource 10x96-Strip-Wells
EUR 6840

Bovine Angiotensinogen (AGT) ELISA Kit

MBS286843-48StripWells MyBiosource 48-Strip-Wells
EUR 480

Bovine Angiotensinogen (AGT) ELISA Kit

MBS286843-5x96StripWells MyBiosource 5x96-Strip-Wells
EUR 3610

Bovine Angiotensinogen (AGT) ELISA Kit

MBS286843-96StripWells MyBiosource 96-Strip-Wells
EUR 805

Bovine Angiotensinogen (AGT) ELISA Kit

MBS2608749-10x96StripWells MyBiosource 10x96-Strip-Wells
EUR 3545

Bovine Angiotensinogen (AGT) ELISA Kit

MBS2608749-48StripWells MyBiosource 48-Strip-Wells
EUR 310

Bovine Angiotensinogen (AGT) ELISA Kit

MBS2608749-5x96StripWells MyBiosource 5x96-Strip-Wells
EUR 1940

Bovine Angiotensinogen (AGT) ELISA Kit

MBS2608749-96StripWells MyBiosource 96-Strip-Wells
EUR 475

Bovine Angiotensinogen(AGT) ELISA Kit

NSL1748Bo Sunlong 96 T
EUR 528
Description: Sandwich ELISA

Recombinant Angiotensinogen (AGT)

MBS2010720-001mg MyBiosource 0.01mg
EUR 180

Recombinant Angiotensinogen (AGT)

MBS2010720-005mg MyBiosource 0.05mg
EUR 330

Recombinant Angiotensinogen (AGT)

MBS2010720-01mg MyBiosource 0.1mg
EUR 500

Recombinant Angiotensinogen (AGT)

MBS2010720-02mg MyBiosource 0.2mg
EUR 615

Recombinant Angiotensinogen (AGT)

MBS2010720-05mg MyBiosource 0.5mg
EUR 1170

Recombinant Angiotensinogen (AGT)

MBS2009330-001mg MyBiosource 0.01mg
EUR 155

Recombinant Angiotensinogen (AGT)

MBS2009330-005mg MyBiosource 0.05mg
EUR 260

Recombinant Angiotensinogen (AGT)

MBS2009330-01mg MyBiosource 0.1mg
EUR 375

Recombinant Angiotensinogen (AGT)

MBS2009330-02mg MyBiosource 0.2mg
EUR 460

Recombinant Angiotensinogen (AGT)

MBS2009330-05mg MyBiosource 0.5mg
EUR 860

Recombinant Angiotensinogen (AGT)

MBS2011101-001mg MyBiosource 0.01mg
EUR 155

Recombinant Angiotensinogen (AGT)

MBS2011101-005mg MyBiosource 0.05mg
EUR 260

Recombinant Angiotensinogen (AGT)

MBS2011101-01mg MyBiosource 0.1mg
EUR 375

Recombinant Angiotensinogen (AGT)

MBS2011101-02mg MyBiosource 0.2mg
EUR 460

Recombinant Angiotensinogen (AGT)

MBS2011101-05mg MyBiosource 0.5mg
EUR 860

Recombinant Angiotensinogen (AGT)

MBS2010533-001mg MyBiosource 0.01mg
EUR 180

Recombinant Angiotensinogen (AGT)

MBS2010533-005mg MyBiosource 0.05mg
EUR 330

Recombinant Angiotensinogen (AGT)

MBS2010533-01mg MyBiosource 0.1mg
EUR 500

Recombinant Angiotensinogen (AGT)

MBS2010533-02mg MyBiosource 0.2mg
EUR 615

Recombinant Angiotensinogen (AGT)

MBS2010533-05mg MyBiosource 0.5mg
EUR 1170

Recombinant Angiotensinogen (AGT)

RPA797Hu01 Cloud-Clone 10ug
EUR 194

Recombinant Angiotensinogen (AGT)

4-RPA797Hu01 Cloud-Clone
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Human Angiotensinogen expressed in: E.coli

Recombinant Angiotensinogen (AGT)

RPA797Hu02 Cloud-Clone 10ug
EUR 194

Recombinant Angiotensinogen (AGT)

4-RPA797Hu02 Cloud-Clone
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Human Angiotensinogen expressed in: E.coli

Recombinant Angiotensinogen (AGT)

RPA797Mu01 Cloud-Clone 10ug
EUR 140

Recombinant Angiotensinogen (AGT)

4-RPA797Mu01 Cloud-Clone
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Mouse Angiotensinogen expressed in: E.coli

Recombinant Angiotensinogen (AGT)

RPA797Ra01 Cloud-Clone 10ug
EUR 140

Recombinant Angiotensinogen (AGT)

4-RPA797Ra01 Cloud-Clone
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 mg
  • 10ug
  • 50ug
  • 100 ug
  • 200 ug
  • 500 ug
  • 1 mg
Description: Recombinant Rat Angiotensinogen expressed in: E.coli

Recombinant Angiotensinogen (AGT)

RPU40285-100ug Biomatik Corporation 100ug
EUR 599.5

Recombinant Angiotensinogen (AGT)

RPU40285-1mg Biomatik Corporation 1mg
EUR 2653.3

Recombinant Angiotensinogen (AGT)

RPU40285-50ug Biomatik Corporation 50ug
EUR 480.7

Recombinant Angiotensinogen (AGT)

RPU40286-100ug Biomatik Corporation 100ug
EUR 431.2

Recombinant Angiotensinogen (AGT)

RPU40286-1mg Biomatik Corporation 1mg
EUR 1911

Recombinant Angiotensinogen (AGT)

RPU40286-50ug Biomatik Corporation 50ug
EUR 346.5

Recombinant Angiotensinogen (AGT)

RPU40287-100ug Biomatik Corporation 100ug
EUR 431.2

Recombinant Angiotensinogen (AGT)

RPU40287-1mg Biomatik Corporation 1mg
EUR 1911

Recombinant Angiotensinogen (AGT)

RPU40287-50ug Biomatik Corporation 50ug
EUR 346.5

Recombinant Angiotensinogen (AGT)

RPU40288-100ug Biomatik Corporation 100ug
EUR 599.5

Recombinant Angiotensinogen (AGT)

RPU40288-1mg Biomatik Corporation 1mg
EUR 2653.3

Recombinant Angiotensinogen (AGT)

RPU40288-50ug Biomatik Corporation 50ug
EUR 480.7

Recombinant Angiotensinogen (AGT)

RPU56827-100ug Biomatik Corporation 100ug
EUR 470.4

Recombinant Angiotensinogen (AGT)

RPU56827-1mg Biomatik Corporation 1mg
EUR 2184

Recombinant Angiotensinogen (AGT)

RPU56827-50ug Biomatik Corporation 50ug
EUR 385

Recombinant Human Angiotensinogen

MBS954800-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1320

Recombinant Human Angiotensinogen

MBS954800-002mgMammalianCell MyBiosource 0.02mg(Mammalian-Cell)
EUR 1585

Recombinant Human Angiotensinogen

MBS954800-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Human Angiotensinogen

MBS954800-01mgBaculovirus MyBiosource 0.1mg(Baculovirus)
EUR 1900

Recombinant Human Angiotensinogen

MBS954800-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1270

Recombinant Rat Angiotensinogen (Agt)

MBS950608-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1320

Recombinant Rat Angiotensinogen (Agt)

MBS950608-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1010

Recombinant Rat Angiotensinogen (Agt)

MBS950608-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Rat Angiotensinogen (Agt)

MBS950608-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1180

Recombinant Rat Angiotensinogen (Agt)

MBS950608-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1270

Recombinant Horse Angiotensinogen (AGT)

MBS718491-005mgBaculovirus MyBiosource 0.05mg(Baculovirus)
EUR 875

Recombinant Horse Angiotensinogen (AGT)

MBS718491-005mgEColi MyBiosource 0.05mg(E-Coli)
EUR 490

Recombinant Horse Angiotensinogen (AGT)

MBS718491-005mgYeast MyBiosource 0.05mg(Yeast)
EUR 695

Recombinant Horse Angiotensinogen (AGT)

MBS718491-02mgEColi MyBiosource 0.2mg(E-Coli)
EUR 645

Recombinant Horse Angiotensinogen (AGT)

MBS718491-05mgEColi MyBiosource 0.5mg(E-Coli)
EUR 700

Recombinant Sheep Angiotensinogen (AGT)

MBS948831-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1320

Recombinant Sheep Angiotensinogen (AGT)

MBS948831-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1010

Recombinant Sheep Angiotensinogen (AGT)

MBS948831-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Sheep Angiotensinogen (AGT)

MBS948831-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1180

Recombinant Sheep Angiotensinogen (AGT)

MBS948831-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1270

Recombinant Mouse Angiotensinogen (Agt)

MBS949091-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1320

Recombinant Mouse Angiotensinogen (Agt)

MBS949091-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1010

Recombinant Mouse Angiotensinogen (Agt)

MBS949091-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Mouse Angiotensinogen (Agt)

MBS949091-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1180

Recombinant Mouse Angiotensinogen (Agt)

MBS949091-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1270

Angiotensinogen Recombinant Rabbit mAb

BS48837 Bioworld Biotech 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Angiotensinogen Recombinant Rabbit mAb

BS49196 Bioworld Biotech 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Angiotensinogen Recombinant Rabbit mAb

BS45966 Bioworld Biotech 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Angiotensinogen Recombinant Rabbit mAb

BS47031 Bioworld Biotech 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Angiotensinogen Recombinant Rabbit mAb

BS47858 Bioworld Biotech 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Recombinant Chicken Angiotensinogen (AGT)

MBS964225-005mgBaculovirus MyBiosource 0.05mg(Baculovirus)
EUR 875

Recombinant Chicken Angiotensinogen (AGT)

MBS964225-005mgEColi MyBiosource 0.05mg(E-Coli)
EUR 485

Recombinant Chicken Angiotensinogen (AGT)

MBS964225-005mgYeast MyBiosource 0.05mg(Yeast)
EUR 705

Recombinant Chicken Angiotensinogen (AGT)

MBS964225-02mgEColi MyBiosource 0.2mg(E-Coli)
EUR 635

Recombinant Chicken Angiotensinogen (AGT)

MBS964225-05mgEColi MyBiosource 0.5mg(E-Coli)
EUR 700

Recombinant Human Angiotensinogen Protein

MBS9141858-002mg MyBiosource 0.02mg
EUR 195

Recombinant Human Angiotensinogen Protein

MBS9141858-005mg MyBiosource 0.05mg
EUR 280

Recombinant Human Angiotensinogen Protein

MBS9141858-01mg MyBiosource 0.1mg
EUR 385

Recombinant Human Angiotensinogen Protein

MBS9141858-5x01mg MyBiosource 5x0.1mg
EUR 1555

Recombinant Human Angiotensinogen (AGT), partial

CSB-EP001463HU1 Cusabio 508 mg Ask for price

Recombinant Human Angiotensinogen (AGT), partial

CSB-EP001463HU1-20ug Cusabio 20ug Ask for price
Description: 44-427aa

Recombinant Human Angiotensinogen(AGT),partial

AP76501 SAB 1mg
EUR 1978

Recombinant Human Angiotensinogen (AGT), partial

MBS7110813-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 255

Recombinant Human Angiotensinogen (AGT), partial

MBS7110813-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 405

Recombinant Human Angiotensinogen (AGT), partial

MBS7110813-1mgEColi MyBiosource 1mg(E-Coli)
EUR 1425

Recombinant Human Angiotensinogen (AGT), partial

MBS7110813-5x1mgEColi MyBiosource 5x1mg(E-Coli)
EUR 6215

Recombinant Human Angiotensinogen/AGT Protein

RP01021 Abclonal 5 μg
EUR 209.01

Recombinant Mouse Angiotensinogen/AGT Protein

RP01621 Abclonal 100μg
EUR 41.8

Recombinant Human Angiotensinogen, His-tagged

AGT-2182H Creative BioMart 10ug
EUR 238.4
Description: Avoid repeated freeze/thaw cycles. Store at 2-8-deg-C for one month. Aliquot and store at -80-deg-C for 12 months.

Recombinant Pan troglodytes Angiotensinogen (AGT)

MBS1474316-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1320

Recombinant Pan troglodytes Angiotensinogen (AGT)

MBS1474316-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1010

Recombinant Pan troglodytes Angiotensinogen (AGT)

MBS1474316-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Pan troglodytes Angiotensinogen (AGT)

MBS1474316-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1180

Recombinant Pan troglodytes Angiotensinogen (AGT)

MBS1474316-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1270

Angiotensinogen (AGT) (NM_000029) Human Recombinant Protein

E45H40174M5 EnoGene 20 ug
EUR 785.42

Recombinant Human Angiotensinogen Protein, His Tag

E40KMP1417 EnoGene 20ug
EUR 495

Angiotensinogen Protein, Human, Recombinant (His Tag)

E45H51255M2-50 EnoGene 50 ug
EUR 870.73

Angiotensinogen Protein, Mouse, Recombinant (His Tag)

E45M52669M2-100 EnoGene 100 ug
EUR 1046.77

Angiotensinogen Protein, Mouse, Recombinant (His Tag)

MBS8122693-01mg MyBiosource 0.1mg
EUR 395

Angiotensinogen Protein, Mouse, Recombinant (His Tag)

MBS8122693-5x01mg MyBiosource 5x0.1mg
EUR 1635

Angiotensinogen Protein, Human, Recombinant (His Tag)

MBS8120618-005mg MyBiosource 0.05mg
EUR 340

Angiotensinogen Protein, Human, Recombinant (His Tag)

MBS8120618-5x005mg MyBiosource 5x0.05mg
EUR 1380

Recombinant Callithrix jacchus Angiotensinogen (AGT)

MBS1361828-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1320

Recombinant Callithrix jacchus Angiotensinogen (AGT)

MBS1361828-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1010

Recombinant Callithrix jacchus Angiotensinogen (AGT)

MBS1361828-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Callithrix jacchus Angiotensinogen (AGT)

MBS1361828-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1180

Recombinant Callithrix jacchus Angiotensinogen (AGT)

MBS1361828-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1270

Recombinant Human Angiotensinogen protein (C-6His)

CD02340-10ug Jiaxing Korain Biotech Ltd (BT Labs) 10ug
EUR 353
Description: Recombinant Human Serine Protease Inhibitor-clade A8 is produced by our Mammalian expression system and the target gene encoding Asp34-Ala485 is expressed with a 6His tag at the C-terminus.

Recombinant Human Angiotensinogen protein (C-6His)

CD02340-50ug Jiaxing Korain Biotech Ltd (BT Labs) 50ug
EUR 1035
Description: Recombinant Human Serine Protease Inhibitor-clade A8 is produced by our Mammalian expression system and the target gene encoding Asp34-Ala485 is expressed with a 6His tag at the C-terminus.

Recombinant Rat Angiotensinogen/AGT protein (His tag)

MBS2571490-002mg MyBiosource 0.02mg
EUR 305

Recombinant Rat Angiotensinogen/AGT protein (His tag)

MBS2571490-01mg MyBiosource 0.1mg
EUR 490

Recombinant Rat Angiotensinogen/AGT protein (His tag)

MBS2571490-5x01mg MyBiosource 5x0.1mg
EUR 2185

Recombinant Rat Angiotensinogen/AGT protein (His tag)

PDMR100022-100ug Elabscience Biotech 100ug
EUR 499
Description: Rat

Recombinant Rat Angiotensinogen/AGT protein (His tag)

PDMR100022-20ug Elabscience Biotech 20ug
EUR 299
Description: Rat

Recombinant Human Angiotensinogen, His-GST-tagged

AGT-2183H Creative BioMart 10ug
EUR 238.4
Description: Avoid repeated freeze/thaw cycles. Store at 2-8-deg-C for one month. Aliquot and store at -80-deg-C for 12 months.

Recombinant Human Angiotensinogen/AGT Protein (His Tag)

PKSH032069-10ug Elabscience Biotech 10ug
EUR 223
Description: Human

Recombinant Human Angiotensinogen/AGT Protein (His Tag)

PKSH032069-50ug Elabscience Biotech 50ug
EUR 593
Description: Human

Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT)

MBS1450817-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1320

Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT)

MBS1450817-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1010

Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT)

MBS1450817-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT)

MBS1450817-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1180

Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT)

MBS1450817-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1270

Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His)

AP75516 SAB 1mg
EUR 3489

Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His)

CB56-10ug Novoprotein 10ug
EUR 242.4
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His)

CB56-1mg Novoprotein 1mg
EUR 2983.2
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His)

CB56-500ug Novoprotein 500ug
EUR 2106
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His)

CB56-50ug Novoprotein 50ug
EUR 595.2
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Coturnix coturnix japonica Angiotensinogen (AGT)

MBS1022338-005mgBaculovirus MyBiosource 0.05mg(Baculovirus)
EUR 875

Recombinant Coturnix coturnix japonica Angiotensinogen (AGT)

MBS1022338-005mgEColi MyBiosource 0.05mg(E-Coli)
EUR 485

Recombinant Coturnix coturnix japonica Angiotensinogen (AGT)

MBS1022338-005mgYeast MyBiosource 0.05mg(Yeast)
EUR 705

Recombinant Coturnix coturnix japonica Angiotensinogen (AGT)

MBS1022338-02mgEColi MyBiosource 0.2mg(E-Coli)
EUR 635

Recombinant Coturnix coturnix japonica Angiotensinogen (AGT)

MBS1022338-05mgEColi MyBiosource 0.5mg(E-Coli)
EUR 700

Angiotensinogen

AP78663 SAB 1mg
EUR 2640

Angiotensinogen

AP80389 SAB 1mg
EUR 2640

Angiotensinogen

AP80434 SAB 1mg
EUR 2640

Angiotensinogen

AP80686 SAB 1mg
EUR 2640

Angiotensinogen

AP80847 SAB 1mg
EUR 2640

Angiotensinogen

E8ET1612-48 EnoGene 100ul
EUR 275
Description: Available in various conjugation types.

Angiotensinogen

MBS8534155-01mL MyBiosource 0.1mL
EUR 345

Angiotensinogen

MBS8534155-01mLAF405L MyBiosource 0.1mL(AF405L)
EUR 565

Angiotensinogen

MBS8534155-01mLAF405S MyBiosource 0.1mL(AF405S)
EUR 565

Angiotensinogen

MBS8534155-01mLAF610 MyBiosource 0.1mL(AF610)
EUR 565
×

Paw irritation, bone quantity (BV), and paw quantity (PV) had been assessed. Histologically, the entrance paws had been assessed for joint irritation, cartilage injury, and pre/osteoclast-like cells and the lumbar spinal wire and the periaqueductal grey (PAG) area of the mind for glial reactivity. A average CAIA dose induced (1) considerably larger native paw irritation, inflammatory cell infiltration, and PV; (2) considerably extra osteoclast-like cells on the bone floor and inside the surrounding comfortable tissue; and (3) considerably larger glial reactivity inside the PAG in contrast with the delicate CAIA mannequin. These findings assist the use of a average CAIA mannequin (increased dose of monoclonal antibodies with low-dose lipopolysaccharide) to induce extra constant histopathological options, with out extreme joint destruction.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

  • 4 Host
  • 96T
  • apoptosis
  • array
  • Assay
  • Bacteria
  • Blocking
  • Combination of pembrolizumab and 125I attenuates the aggressiveness of non-small cell lung cancer.
  • Comparison of Efficacy of Topical Curcumin Gel with Triamcinolone-hyaluronidase Gel Individually and in Combination in the Treatment of Oral Submucous Fibrosis.
  • Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor.
  • GMO
  • Goat
  • Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma.
  • LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703.
  • Next-generation laser-based photodynamic endoscopic diagnosis using 5-aminolevulinic acid for early gastric adenocarcinoma and gastric adenoma.
  • Pig
  • Pigeon
  • Plant
  • plasmid
  • Plate
  • Prone en-bloc sacrectomy with proctectomy: A surgical approach to the inaccessible and hostile pelvis
  • Sleeve Gastrectomy: Surgical Technique, Outcomes, and Complications

Recent Posts

  • Distributors of Lab PCR Assays
  • Compare recombinant lab reagents for research
  • Compare monoclonal lab reagents for research
  • Compare antibodies lab reagents for research
  • Compare Appoptosis lab reagents for research

Tags

biology cells quiz 3 biology cells quizlet biology cells review biology cells revision flashcards gcse biology cells revision notes gcse cdna.tv cdna2 cdna cds cdnacp cdnaf cdname cdnap cdna stock price cdna synthesis cdna vs dna celia kitchen kempton st new bedford celia kitzinger celia kitzinger york cia kids cia kids camp cia kids classes cia kids code cia kids cooking cia kids games cia kids gov cia kids page cia kids program cia kids zone cia kissing stent cla kids clakids.org clia citation clia kit clia ks cli kit enzymes definition enzymes for adhesions enzymes for cats enzymes for digestion enzymes for digestion of lipids enzymes for dogs enzymes for dogs joints enzymes for drain enzymes for drain pipes enzymes for fat

Recent Posts

  • Distributors of Lab PCR Assays
  • Compare recombinant lab reagents for research
  • Compare monoclonal lab reagents for research
  • Compare antibodies lab reagents for research
  • Compare Appoptosis lab reagents for research
Breast Cancer Antibodies

Categories

  • 4 Host (6)
  • 96T (6)
  • apoptosis (7)
  • array (6)
  • Assay (6)
  • Bacteria (7)
  • Blocking (6)
  • Combination of pembrolizumab and 125I attenuates the aggressiveness of non-small cell lung cancer. (1)
  • Comparison of Efficacy of Topical Curcumin Gel with Triamcinolone-hyaluronidase Gel Individually and in Combination in the Treatment of Oral Submucous Fibrosis. (1)
  • Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor. (1)
  • GMO (6)
  • Goat (6)
  • Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma. (1)
  • LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703. (1)
  • Next-generation laser-based photodynamic endoscopic diagnosis using 5-aminolevulinic acid for early gastric adenocarcinoma and gastric adenoma. (1)
  • Pig (6)
  • Pigeon (6)
  • Plant (6)
  • plasmid (6)
  • Plate (5)
  • Prone en-bloc sacrectomy with proctectomy: A surgical approach to the inaccessible and hostile pelvis (1)
  • Sleeve Gastrectomy: Surgical Technique, Outcomes, and Complications (34)

Categories

  • 4 Host
  • 96T
  • apoptosis
  • array
  • Assay
  • Bacteria
  • Blocking
  • Combination of pembrolizumab and 125I attenuates the aggressiveness of non-small cell lung cancer.
  • Comparison of Efficacy of Topical Curcumin Gel with Triamcinolone-hyaluronidase Gel Individually and in Combination in the Treatment of Oral Submucous Fibrosis.
  • Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor.
  • GMO
  • Goat
  • Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma.
  • LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703.
  • Next-generation laser-based photodynamic endoscopic diagnosis using 5-aminolevulinic acid for early gastric adenocarcinoma and gastric adenoma.
  • Pig
  • Pigeon
  • Plant
  • plasmid
  • Plate
  • Prone en-bloc sacrectomy with proctectomy: A surgical approach to the inaccessible and hostile pelvis
  • Sleeve Gastrectomy: Surgical Technique, Outcomes, and Complications
© 2025 Sialix Cancer Research | Powered by Superbs Personal Blog theme